How we make money
Referral fees, and nothing else. When we introduce you to a provider and you go on to use them, that provider pays us. Everything below is what that does and does not mean.
What it means for you
- It does not change your price. The fee comes out of the provider's marketing budget, not your bill.
- It does not change the order. Providers are listed the same way whether they pay us or not, and several of the companies on this site pay us nothing at all.
- It cannot buy a finding. No provider can pay to be added, to be ranked, or to have an audit result removed or softened.
What we will never do
- No display advertising. Not now, not later. It is incompatible with the rule below and worth almost nothing on pages like these anyway.
- No links on an unapproved compound. A commercial link may only sit on a page about a drug the regulator here has approved. Intended use is inferred from surrounding content, and a link is surrounding content. It is enforced by a test in this codebase, not by memory.
- No guaranteed savings. Nobody can know what your plan will do before it does it.
- No advice. We publish information. What to do with it is between you and a prescriber.
Every rail we are paid by
The whole list, including the ones we have applied to and not been accepted onto yet. A blank rate means the program does not publish one and we have not been told it. The dates are when we last read the published terms.
| Rail | What for | What they pay us | Status |
|---|---|---|---|
| Hims & Hers | Telehealth prescribing branded Wegovy through a Novo Nordisk agreement | Katalys publishes $60 CPA. 🔴 Ask whether a CPL is available on this programme before accepting the CPA | Not yet applied |
| Katalys | A telehealth affiliate network, including providers offering peptide therapy | Network carrying 25 GLP-1 brands. 🔴 ASK FOR CPL, NOT CPA: $20 to $60 on an intake form at 10 to 20% of clicks, against $5 to $75 on a shipped order at 1 to 3%. The reachable BRANDED band is $5 to $75; the $228 to $500 offers are compounded and rule 2 forbids the link | Not yet applied |
| Hims & Hers via Impact | The same advertiser on a second network. Pick one, never both | Reported $20 to $40 per new subscription via Impact. 🔴 Ask for CPL. 🔴 Do not run alongside the Awin rail | Not yet applied |
| Marek Health | Hormone optimisation and lab panels through a LabCorp partnership | Unpublished. Needs a rate conversation on application | Not yet applied |
| Claimable | AI-assisted insurance appeals for denied claims, including GLP-1 denials | Per-appeal fee. No published affiliate programme; approach direct | Not yet applied |
-
Hims & Hers Not yet applied
Telehealth prescribing branded Wegovy through a Novo Nordisk agreement
Katalys publishes $60 CPA. 🔴 Ask whether a CPL is available on this programme before accepting the CPA
-
Katalys Not yet applied
A telehealth affiliate network, including providers offering peptide therapy
Network carrying 25 GLP-1 brands. 🔴 ASK FOR CPL, NOT CPA: $20 to $60 on an intake form at 10 to 20% of clicks, against $5 to $75 on a shipped order at 1 to 3%. The reachable BRANDED band is $5 to $75; the $228 to $500 offers are compounded and rule 2 forbids the link
-
Hims & Hers via Impact Not yet applied
The same advertiser on a second network. Pick one, never both
Reported $20 to $40 per new subscription via Impact. 🔴 Ask for CPL. 🔴 Do not run alongside the Awin rail
-
Marek Health Not yet applied
Hormone optimisation and lab panels through a LabCorp partnership
Unpublished. Needs a rate conversation on application
-
Claimable Not yet applied
AI-assisted insurance appeals for denied claims, including GLP-1 denials
Per-appeal fee. No published affiliate programme; approach direct
Why we print all of this
Because the alternative is a line of small print nobody reads, and because the reader of a page like this is usually deciding whether we are a reference or a lead farm. The honest answer is that we are both paid and useful, and the way to prove the second is to be completely plain about the first.